Ophthalmology Billing Services // 2026
The 2026 win is a first-pass clean claim, not a bigger fee schedule.
For a solo comprehensive ophthalmology practice with a co-located retina service, 2026 tightens the two levers that carry your revenue: eye-code versus E/M selection under frequency edits, and buy-and-bill anti-VEGF drug capture with mandatory waste modifiers. With the cataract 66984 payment down about 11 percent, the margin now lives in coding that survives the first submission.
The decision that repeats every visit
Eye codes (92xxx) versus E/M (99xxx)
Both code families describe an office visit, but they are scored and audited differently. Eye codes reward a documented, matched examination; E/M rewards medical decision making or time. Pick the family that the record actually supports, then respect the payer frequency edits that cap how often each is reimbursed.
Eye codes
92002 - 92014- Scored on the ophthalmologic examination elements, not MDM tables
- Intermediate vs comprehensive; 92014 needs the full exam plus an initiated or continued treatment program
- Strong fit for cataract evaluation, glaucoma surveillance, and diabetic eye exams
- Watch same-day frequency edits: many MACs pay one eye-code exam per encounter
E/M codes
99202 - 99215- Scored on medical decision making or total time on the date of service
- Better when the problem count, data reviewed, or risk drives the level higher than the exam does
- Cleaner support for new comorbidity work-ups and multi-problem retina visits
- Time-based selection needs a time statement, not just a template
Fee-schedule math // buy-and-bill
Anti-VEGF is a drug-margin business, so protect every unit
Co-located retina means buy-and-bill J-codes flow through your fee schedule at ASP plus 6 percent. The reimbursement is thin per unit and unforgiving on documentation. Every single-use vial has to reconcile: the administered dose on the drug line, the discarded remainder on a JW line, and a JZ attestation when nothing is wasted.
| Service line | Code | What it captures |
|---|---|---|
| Aflibercept | J0178 | Administered dose, per unit billed |
| Ranibizumab | J2778 | Administered dose, per unit billed |
| Faricimab | J2777 | Administered dose, per unit billed |
| Intravitreal injection | 67028 | The procedure, eye laterality via RT / LT |
| Drug waste | JW | Discarded amount from single-use vial |
| Zero waste | JZ | Attestation that no amount was discarded |
Part B drug payment
Illustrative benchmark figures for structure only, not a quoted rate. Actual ASP files update quarterly. A missing JW or JZ modifier is now a first-pass denial trigger, and step therapy may require a documented preferred-agent trial before the payer covers the billed drug.
Coverage rules that decide the claim
Medical necessity lives in the LCD, not the chart note alone
Each of these is controlled by a published MAC or LCD standard. The claim clears when the record maps to the standard, and denies when it maps to a habit. Every card below carries the governing source line.
1Cataract surgery
Coverage rests on documented functional impairment, difficulty with driving, reading, or activities of daily living, not on hitting a fixed Snellen acuity number. Pair the acuity with the functional history and the surgeon's plan.
2YAG capsulotomy
The 90-day global period after cataract surgery governs. A YAG (66821) inside that window on the same eye typically bundles unless clearly a separate, medically necessary event with a modifier that the record supports.
3Blepharoplasty
Functional bleph needs the margin reflex distance threshold met (MRD-1 at or below the payer limit) plus matched external and visual-field photographs. Cosmetic ptosis correction without the documentation is patient-pay.
4OCT and SCODI
Scanning ophthalmic diagnostic imaging (92133 / 92134) is frequency-limited by diagnosis. Repeat OCT beyond the covered interval without a documented clinical change is a predictable denial.
The cataract cut changes the math, not the mission
With 66984 down roughly 11 percent in 2026, you cannot recover the difference by coding higher. You recover it by denying fewer claims: complete functional-impairment notes, correct laterality, clean global-period handling, and premium-IOL amounts routed to patient-pay where the payer covers only the conventional lens. The clean-claim rate is now the revenue lever.
Modifier reference
The modifiers that keep same-day and surgical claims intact
Co-management with an operating surgeon requires the -54 / -55 split to match the actual transfer-of-care date, or both parties risk a duplicate or overpayment recovery.
Ophthalmology billing services built for the 2026 rulebook
ASP-RCM codes ophthalmology and retina the way the payers now adjudicate it: eye-code versus E/M selection driven by the record, LCD-mapped medical necessity, and buy-and-bill drug capture with every JW and JZ line reconciled before the claim leaves the door. That is how a thinner 66984 still nets a healthy month.
Industry first-pass coding accuracy commonly benchmarks lower, which is exactly the gap a specialized ophthalmology team closes. Benchmarks shown are illustrative industry figures, not client actuals.
Book an ophthalmology billing reviewRelated reading
Eye Codes or E/M: The 2026 Ophthalmology Visit-Selection Decision
A 2026 decision guide and interactive calculator for optometry and ophthalmology billing: compare eye codes (9
Read →BriefingEye Codes or E/M in 2026? The comparison most practices keep getting backward.
When eye codes (92002-92014) beat office E/M (99202-99215) in 2026, when E/M wins, and the 67028 injection-day
Read →Field noteTwo code families see the same patient. Only one survives the audit.
A side-by-side matrix comparing CPT eye codes 92002-92014 against office E/M on documentation demands and freq
Read →